doi: 10.1530/EC-23-0005 PMID: 37159343 Pronunciation: kan-a-gli-FLOE-zin Dapagliflozin (Farxiga ) Trade Names: Farxiga (Forxiga in Europe) Drug Class: Anti-diabetic drug, Hypoglycemic, SGLT-2 inhibitor, Gliflozin Pharmacology is similar to canagliflozin, the other SGLT-2 inhibitor in this drug class Mechanism of Action: Hypoglycemic : Inhibits the Na-glucose co-transporter 2 (SGLT-2) in the kidney to reduce glucose reabsorption, resulting in increased urinary glucose excretion, and lower plasma glucose
Like the FDA, Australias Therapeutic Goods Administration responded to the shortage by opening the door to knockoffs
Raynauds phenomenon: Vasodilatory effect of amlodipine aids in digital perfusion
Imaging can also be used to look at other organ-specific effects, which the field is beginning to understand better thanks to the various trials that have been conducted and are still ongoing in the heart, liver, kidneys, and to a lesser extent, the brain
What makes this run more remarkable is that it included a challenging past year
Patients taking Ozempic should be aware of red flag symptoms that indicate the need for urgent assessment